Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters.
Pruunsild P, Kazantseva A, Aid T, Palm K, Timmusk T. · 2007
Read Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters. by Pruunsild P, Kazantseva A, Aid T, Palm K, Timmusk T. (2007) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2568880.txt.
Introduction
Pruunsild, Kazantseva, Aid, Palm, and Timmusk dissected the human BDNF gene in this 2007 study. BDNF is a growth factor that supports neurons and shapes learning, memory, and pain, and its gene was known to be complicated. The team mapped the gene's full structure. They catalogued its alternative transcripts. They also tested where each version is switched on in adult tissues and brain regions.
They found 11 exons and nine working promoters, each used in specific tissues or brain areas. A partner gene on the opposite strand, called antiBDNF, produces noncoding RNAs with their own complex patterns. In the brain, BDNF and antiBDNF transcripts pair up into double strands. This suggests the antisense partner helps control how much BDNF is made in humans.
Catalog record
| CREATOR | Pruunsild P, Kazantseva A, Aid T, Palm K, Timmusk T. |
|---|---|
| YEAR | 2007 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Dissecting the human BDNF locus: Bidirectional transcription, complex splicing, and multiple promoters☆ By Priit Pruunsild, Anna Kazantseva1, Tamara Aid, Kaia Palm, Tõnis Timmusk Published in: Genomics DOI: 10.1016/j.ygeno.2007.05.004 ABSTRACT Abstract Brain-derived neurotrophic factor (BDNF), a member of the nerve growth factor family of neurotrophins, has central roles in the development, physiology, and pathology of the nervous system. We have elucidated the structure of the human BDNF gene, identified alternative transcripts, and studied their expression in adult human tissues and brain regions. In addition, the transcription initiation sites for human BDNF transcripts were determined and the activities of BDNF promoters were analyzed in transient overexpression assays. Our results show that the human BDNF gene has 11 exons and nine functional promoters that are used tissue and brain-region specifically. Furthermore, noncoding natural antisense RNAs that display complex splicing and expression patterns are transcribed in the BDNF gene locus from the antiBDNF gene (approved gene symbol BDNFOS). We show that BDNF and antiBDNF transcripts form dsRNA duplexes in the brain in vivo, suggesting an important role for antiBDNF in regulating BDNF expression in human. Keywords: Neurotrophic factor, Brain, neuron, Alternative splicing, BDNF, Natural antisense transcript, RNA duplex, Lin-7c/Mals-3/veli3 Brain-derived neurotrophic factor (BDNF) is a member of the nerve growth factor family of neurotrophins. During development BDNF supports the survival and differentiation of selected neuronal populations of the peripheral and central nervous systems and participates in axonal growth and pathfinding and in the modulation of dendritic growth and morphology [1,2]. BDNF also has a prominent role in later stages of nervous system development and in the adult by regulating synaptic transmission and plasticity and acts as a central modulator of pain [3]. BDNF has been shown to be a modulator of synaptogenesis in vivo [4] and has a functional role in the expression of LTP in the hippocampus [5]. Data accumulated in recent years suggest that neuronal activity regulates transcription of BDNF, transport of BDNF mRNA and protein into dendrites, and secretion of BDNF protein, which are important for the formation of appropriate synaptic connections and for learning and memory during development and in adults [6]. A single-nucleotide polymorphism in the human BDNF gene, resulting in a valine to methionine substitution (Val66Met) in the prodomain, has been shown to lead to reduced activity-induced BDNF secretion and memory impairment [7]. BDNF signaling has been shown to be critical in several neuropsychiatric and neurodegenerative diseases [1], for example, Huntington disease [8]. These results taken together show that BDNF has numerous important roles in brain development, physiology, and pathology. During development, BDNF protein expression is more abundant in the nervous system compared to other tissues and its levels are dramatically increased in the brain during postnatal development [9]. In the adult nervous system, BDNF displays a widespread distribution pattern, with the highest levels of mRNA and protein in the hippocampus, amygdala, cerebral cortex, and hypothalamus [9–12]. BDNF mRNA expression is mostly confined to neurons and there are only a few brain areas where BDNF mRNA is not detected [10–12]. BDNF expression in adult tissues is detectable also outside of the central nervous system. Lower BDNF mRNA levels than in the hippocampus have been detected in the thymus, liver, spleen, heart, and lung [9,11,13,14]. The structure and regulation of the BDNF gene have been studied in rodents [15–17]. Mouse and rat BDNF genes have eight 5′ exons containing separate promoters upstream of each exon and one 3′ exon encoding the mature BDNF protein [17]. Multiple promoters determine tissue-specific expression of the BDNF transcripts [15,17]. The human BDNF has also been shown to consist of multiple 5′ noncoding exons and one coding exon, which give rise to alternatively spliced transcripts [18–20]. According to the most recent description of the organization of the human BDNF gene locus and alternatively spliced transcripts the human BDNF has seven noncoding and one coding exon [19]. Provided that only a partial description of the transcripts was given and expression of the alternative transcripts was studied in only a few brain regions and was not investigated in human nonneural tissues, we undertook the current study to analyze thoroughly the structure of the human BDNF gene, characterize the expression of alternatively spliced BDNF mRNAs in different human tissues and brain regions, and identify and study the activities of alternative human BDNF promoters. RESULTS Structure and alternative splicing of human BDNF and antiBDNF (approved gene symbol BDNFOS) To reexamine the human BDNF gene structure and identify mRNAs transcribed from the gene, in silico analysis, 5′ rapid amplification of cDNA ends (5′ RACE), and RT-PCR analyses were performed. First, all BDNF mRNAs and expressed sequence tags (ESTs) available at the NCBI database (http://www.ncbi.nlm.nih.gov) were analyzed. Primers designed for PCR analyses are presented in Supplementary Table 1. Total RNAs of the adult human frontal cerebral cortex, medulla, and hippocampus were used as templates in the RT-PCR. Second, to identify novel BDNF transcripts and to determine the transcription start sites for the human BDNF transcripts, 5′ RACE of human adult hippocampal and cerebellar RNA was performed using antisense primers specific for the 3′ exon and for the 5′ exons (Supplementary Table 1). BDNF gene exon–intron boundaries and genomic locations were determined by BLAT algorithm (http://genome.ucsc.edu/cgi-bin/hgBlat) and by direct comparison of PCR-amplified sequences with genomic DNA sequence from the NCBI database (Accession No. AF411339). The designation of the human BDNF exons in this study is consistent with the naming of the mouse and rat BDNF exons described in the study by Aid et al. [17]. The exons unique to human BDNF are marked with the letter “h” and are named with the same number as the neighboring upstream exon. Our analysis showed that the human BDNF gene spans ∼ 70 kb and consists of 11 exons (Fig. 1). hBDNF exons named by Liu et al. [19] are designated here as old exons. Comparison of our data with that of Liu et al. [19] shows that exons I–IV correspond to the respective old exons; exons V, Vh, VIII, and VIIIh are novel exons; exons VI and VII correspond to old exons V and VI, respectively; and exon IX variants IXb and IXd correspond to old exons VII and VIII, respectively (Fig. 2A). Nine of the exons, I, II, III, IV, V, Vh, VI, VII, and IX, can be defined as 5′ exons (Fig. 1). Cloning and sequencing of the 5′ RACE products revealed that the transcription start sites relative to the 3′ end of the respective exon are located as follows: − 647 and − 428 nt for exon I; − 433, − 423, − 422, − 416, − 407, − 400, − 226, − 224, − 204, − 200, − 78, and − 47 nt for exon II; − 237 and − 191 nt for exon III; − 337, − 333, − 274, and − 215 nt for exon IV; − 82, − 80, and − 79 nt for exon V; − 225 and − 222 nt for exon Vh; − 324; − 323, − 319, − 318, and − 315 nt for exon VI; and − 184 nt for exon VII (Supplementary Fig. 1). We determined that human BDNF transcription starts also from the last exon, exon IX, − 1102